172 related articles for article (PubMed ID: 11862475)
1. Hyperthermia and mafosfamide in a human-derived malignant pleural mesothelioma cell line.
Ehlers EM; Kühnel W; Wiedemann GJ
J Cancer Res Clin Oncol; 2002 Feb; 128(2):65-72. PubMed ID: 11862475
[TBL] [Abstract][Full Text] [Related]
2. The effects of thermochemotherapy using cyclophosphamide plus hyperthermia on the malignant pleural mesothelioma in vivo.
Riehemann K; Schmitt O; Ehlers EM
Ann Anat; 2005 Jul; 187(3):215-23. PubMed ID: 16130821
[TBL] [Abstract][Full Text] [Related]
3. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
Matsuzaki Y; Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):161-5. PubMed ID: 18577894
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide.
Davidoff AN; Mendelow BV
Exp Hematol; 1993 Jul; 21(7):922-7. PubMed ID: 8319782
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
[TBL] [Abstract][Full Text] [Related]
7. Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
Janson V; Behnam-Motlagh P; Henriksson R; Hörstedt P; Engström KG; Grankvist K
Exp Lung Res; 2008 Feb; 34(2):49-67. PubMed ID: 18266129
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Bakhshandeh A; Bruns I; Eberhardt K; Wiedemann GJ
Dtsch Med Wochenschr; 2000 Mar; 125(11):317-9. PubMed ID: 10761473
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
10. Advances in the systemic therapy of malignant pleural mesothelioma.
Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
[TBL] [Abstract][Full Text] [Related]
12. Effects of asbestos on initiation of DNA damage, induction of DNA-strand breaks, P53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells.
Burmeister B; Schwerdtle T; Poser I; Hoffmann E; Hartwig A; Müller WU; Rettenmeier AW; Seemayer NH; Dopp E
Mutat Res; 2004 Mar; 558(1-2):81-92. PubMed ID: 15036122
[TBL] [Abstract][Full Text] [Related]
13. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
15. The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.
Cole GW; Alleva AM; Reddy RM; Maxhimer JB; Zuo J; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2005 May; 129(5):1010-7. PubMed ID: 15867774
[TBL] [Abstract][Full Text] [Related]
16. Biology and management of malignant pleural mesothelioma.
Zucali PA; Giaccone G
Eur J Cancer; 2006 Nov; 42(16):2706-14. PubMed ID: 16989994
[TBL] [Abstract][Full Text] [Related]
17. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
Kobayashi M; Takeuchi T; Ohtsuki Y
Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
[TBL] [Abstract][Full Text] [Related]
18. Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy.
Debes A; Willers R; Göbel U; Wessalowski R
Pediatr Blood Cancer; 2005 Oct; 45(5):663-9. PubMed ID: 15929134
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation.
Cameron RB; Hou D
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):496-504. PubMed ID: 23174177
[TBL] [Abstract][Full Text] [Related]
20. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]